Bioethics, Quality Regulation and Case Reports

Bioethics, Quality Regulation and Case Reports Submit Abstract Register Now
Bioethics is the study of the typically controversial ethical issues emerging from new situations and possibilities brought about by advances in medicine. It is also moral discernment as it relates to medical policy, practice, and research. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, clinical research, and philosophy etc. One of the first areas addressed by modern bioethicists was that of human experimentation. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research was initially established in 1974 to identify the basic ethical principles that should underlie the conduct of biomedical and behavioral research involving human subjects.
 

Improvements in FDA review process efficiency and more frequent and timely interactions with FDA Overall; the therapeutic area with the highest clinical research burden across all phases is respiratory system ($115.3 million) followed by pain and anaesthesia ($105.4 million) and oncology ($78.6 million) trials. Use of lower-cost facilities/in-home testing and wider use of mobile technologies appear to be most effective in reducing costs across therapeutic areas and trial phases. Use of lower-cost facilities and/or in-home testing can reduce per-trial costs by up to $0.8 million (16 percent) in Phase 1, $4.3 million (22 percent) in Phase 2, and $9.1 million (17 percent) in Phase 3, depending on therapeutic area

 
Clinical research ethics are the set of relevant ethics considered in the conduct of a clinical trial in the field of clinical research. It borrows from the broader fields of research ethics and medical ethics. Quality of clinical trials depends on data integrity and subject protection. Globalization, outsourcing and increasing complexity of clinical trials have made the target of achieving global quality challenging. The quality, as judged by regulatory inspections of the investigator sites, sponsors/contract research organizations and Institutional Review Board, has been of concern to the US Food and Drug Administration, as there has been hardly any change in frequency and nature of common deficiencies. Good Clinical Practice (GCP) is the universal ethical and scientific quality standard for conducting clinical trials. The GCP standard applies to all aspects of the clinical trial process.

  • Compliance and regulatory requirements in clinical research
  • Ethical regulatory guidelines
  • Capacity building in clinical research
  • Bioethics: Case studies
  • Pharmacokinetics-Pharmacodynamics for regulatory decision
  • Ethical and regulatory issues

Related Conference of Bioethics, Quality Regulation and Case Reports

January 06-07, 2025

29th Annual Meeting on Pharmaceutical Biotechnology

London, UK
February 24-25, 2025

2nd International Conference on Pharmacognosy

Madrid, Spain
February 27-28, 2025

8th International on Pharmacy and Pharmaceutical Conference

Prague, Czech Republic
March 10-11, 2025

35th Annual European Pharma Congress

Rome, Italy
April 07-08, 2025

4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems

Vancouver, Canada
April 14-15, 2025

18th European Biosimilars Congress

Paris, France
April 24-25, 2025

18th World Drug Delivery Summit

London, UK
May 05-06, 2025

21st International Conference on Pharmaceutical Chemistry

Rome, Italy
May 05-06, 2025

17th International Conference on Pharmaceutical Education and Practice

Vancouver, Canada
May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
May 19-20, 2025

16th Annual Congress on Bioavailability and Bioequivalence

Rome, Italy
May 19-20, 2025

7th International Conference and Exhibition on Pain Management

Zurich, Switzerland
June 02-03, 2025

31st International Conference on Advanced Clinical Research and Clinical Trials

Amsterdam, Netherlands
June 10-11, 2025

24th International Conference on Medicinal and Pharmaceutical Chemistry

Vancouver, Canada
June 10-11, 2025

7th International Conference and Exhibition on Pharmaceutical Development and Technology

Vancouver, Canada
June 16-17, 2025

18th International Conference and Exhibition on Pharmacovigilance & Drug Safety

Frankfurt, Germany
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry

Paris, France
June 23-24, 2025

27th International Congress on Pharmaceutical Biotechnology Research

Paris, France
June 23-24, 2025

38th World Congress on Pharmacology

Aix-en-Provence, France
July 24-25, 2025

5th World Congress on Cardiovascular Medicine Pharmacology

Paris, France
August 21-22, 2025

5th International Conference on Pharmaceutical Chemistry

Dublin, Ireland
September 08-09, 2025

26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

Frankfurt, Germany
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
October 16-17, 2025

18th International Conference on Pharmaceutics and Drug Safety

Berlin, Germany
October 22-23, 2025

7th European Conference on Advance Clinical Trials and Research

Paris, France
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Bioethics, Quality Regulation and Case Reports Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in